Evidence map›Paper›PMID 23568102›Full record

ArticleJournal of Alzheimer's disease : JAD2013

Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.

Lojze M Smid, Vladimir Kepe, Harry V Vinters, Mara Bresjanac, Tatsushi Toyokuni, Nagichettiar Satyamurthy, Koon-Pong Wong, Sung-Cheng Huang, Daniel H S Silverman, Karen Miller and 2 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Bibliometric Analysis of Chronic Traumatic Encephalopathy Research from 1999 to 2019.International journal of environmental research and public health · 2020
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. In Vivo Brain Plaque and Tangle Burden Mediates the Association Between Diastolic Blood Pressure and Cognitive Functioning in Nondemented Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
    Article
  8. Article
  9. Review
  10. Review
  11. New protein deposition tracers in the pipeline.EJNMMI radiopharmacy and chemistry · 2017
    Review
  12. Tau imaging in neurodegenerative diseases.European journal of nuclear medicine and molecular imaging · 2016
    Review
  13. Review
  14. Insight into the Molecular Imaging of Alzheimer's Disease.International journal of biomedical imaging · 2016
    Review
  15. Untangling tau imaging.Alzheimer's & dementia (Amsterdam, Netherlands) · 2016
    Review
  16. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Lojze M SmidDavid Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6948, USA.
Vladimir Kepe
Harry V Vinters
Mara Bresjanac
Tatsushi Toyokuni
Nagichettiar Satyamurthy
Koon-Pong Wong
Sung-Cheng Huang
Daniel H S Silverman
Karen Miller
Gary W Small
Jorge R Barrio
University of California, Los Angeles · USUniversity of Ljubljana · SI

Funding

UCLA ALZHEIMERS DISEASE RESEARCH CENTERP50AG016570 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BREDESEN, DALE E. · 1999 to 2014
$25.9M
VISUALIZING BRAIN A-BETA, TAU /SEROTONIN RECEPTOR DENSITP01AG025831 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALL, GARY WILLIAM · 2005 to 2010
$7.0M
NIA NIH HHS P01 AG025831NIA NIH HHS P01-AG025831NIA NIH HHS P50 AG016570NIA NIH HHS P50 AG 16570
6 · The paper itself

Abstract

This work is aimed at correlating pre-mortem [18F]FDDNP positron emission tomography (PET) scan results in a patient with dementia with Lewy bodies (DLB), with cortical neuropathology distribution determined postmortem in three physical dimensions in whole brain coronal sections. Analysis of total amyloid-β (Aβ) distribution in frontal cortex and posterior cingulate gyrus confirmed its statistically significant correlation with cortical [18F]FDDNP PET binding values (distribution volume ratios, DVR) (p < 0.001, R = 0.97, R2 = 0.94). Neurofibrillary tangle (NFT) distribution correlated significantly with cortical [18F]FDDNP PET DVR in the temporal lobe (p < 0.001, R = 0.87, R2 = 0.76). Linear combination of Aβ and NFT densities was highly predictive of [18F]FDDNP PET DVR through all analyzed regions of interest (p < 0.0001, R = 0.92, R2 = 0.85), and both densities contributed significantly to the model. Lewy bodies were present at a much lower level than either Aβ or NFTs and did not significantly contribute to the in vivo signal. [18F]FDG PET scan results in this patient were consistent with the distinctive DLB pattern of hypometabolism. This work offers a mapping brain model applicable to all imaging probes for verification of imaging results with Aβ and/or tau neuropathology brain distribution using immunohistochemistry, fluorescence microscopy, and autoradiography.

Indexed as

Imaging, Three-DimensionalAgedAmyloid beta-PeptidesBrain MappingCerebral CortexHumansLewy Body DiseaseMaleNeurofibrillary TanglesNitrilesPositron-Emission TomographyPostmortem ChangesPsychiatric Status Rating ScalesReproducibility of Resultstau ProteinsTomography Scanners, X-Ray Computed2-(1-(6-((2-fluoroethyl)(methyl)amino)-2-naphthyl)ethylidene)malononitrileAmyloid beta-PeptidesNitrilestau Proteins

Identifiers

PMID23568102
PMCPMC3688653
OpenAlexW1877218633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.